Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 8,254 | 5,837 | 4,528 | 792 | 1,451 |
| Cost of Goods | 3,908 | 3,394 | 1,854 | 422 | 1,634 |
| Gross Profit | 4,346 | 2,443 | 2,674 | 370 | -183 |
| Operating Expenses | 30,577 | 24,384 | 33,289 | 32,142 | 26,306 |
| Operating Income | -25,323 | -21,547 | -29,761 | -31,350 | -25,855 |
| Interest Expense | 2,052 | 1,427 | 420 | 155 | 199 |
| Other Income | -119 | -242 | 145 | 2,833 | 607 |
| Pre-tax Income | -27,494 | -23,216 | -30,036 | -28,672 | -25,447 |
| Net Income Continuous | -27,494 | -23,216 | -30,036 | -28,672 | -25,447 |
| Net Income | $-27,494 | $-23,216 | $-30,036 | $-28,672 | $-25,447 |
| EPS Basic Total Ops | -0.60 | -0.65 | -1.12 | -1.25 | -1.53 |
| EPS Basic Continuous Ops | -0.60 | -0.65 | -1.12 | -1.25 | -1.53 |
| EPS Diluted Total Ops | -0.60 | -0.65 | -1.12 | -1.25 | -1.53 |
| EPS Diluted Continuous Ops | -0.60 | -0.65 | -1.12 | -1.25 | -1.53 |
| EBITDA(a) | $-23,689 | $-19,157 | $-28,050 | $-29,734 | $-23,735 |